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a b s t r a c t
An elevated ratio of n-6 to n-3 long-chain (LC-) polyunsaturated fatty acids (PUFA) may be a potential
risk factor for obesity development. N-3 LC-PUFA are thought to alter adiponectin concentrations, and
thus may have a beneﬁcial effect on weight development. We analysed the association between n-3 LC-
PUFA concentrations in cord blood and adiponectin concentrations at 10 years.
Fatty acid composition was measured in cord blood and at 10 years of age by gas chromatography,
and adiponectin concentrations were measured only at 10 years of age in 237 children from the Munich
LISAplus birth cohort study. Linear regression models assessed associations between n-3 LC-PUFA, n-6
LC-PUFA and the n-6/n-3 ratio in cord blood with adiponectin concentrations at 10 years of age. LC-PUFA
were presented as percentages and categorized into tertiles. Regression models were adjusted for LC-
PUFA percentages at 10 years of age and other potential confounding factors.
Cord blood n-3 LC-PUFA tertiles were signiﬁcantly associated with adiponectin concentrations in an
inverse J-shaped relationship [2nd tertile versus 1st tertile: Beta=1.84 (SE¼0.65), and 3rd tertile versus
1st tertile: 1.02 (0.68), p-valueo0.01 (ANOVA)]. Further, cord blood n-6/n-3 ratios were signiﬁcantly
associated with adiponectin concentrations [2nd tertile versus 1st tertile: 0.14 (0.67), and 3rd tertile
versus 1st tertile: 1.37 (0.68), p-value¼0.03 (ANOVA)]. The cord blood n-6 LC-PUFA tertiles were not
associated with adiponectin concentrations.
Our results suggest that a higher n-3 LC-PUFA concentrations and a lower n-6/n-3 ratio in cord blood
are associated with higher adiponectin concentrations at 10 years of age.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
It has been suggested that, among other factors, an elevated ratio
of n-6 to n-3 long-chain polyunsaturated fatty acids (LC-PUFA) may be
a potential risk factor for obesity [1,2].
N-6 LC-PUFA and n-3 LC-PUFA been proposed to have different
effects on the development of adipose tissue. The main n-6 LC-
PUFA, arachidonic acid (AA), is a precursor of eicosanoids, such as
prostacyclin, which enhances the differentiation of adipose pre-
cursor cells to adipocytes. In contrast, n-3 LC-PUFA eicosapentae-
noic acid (EPA) and docosahexaenoic acid (DHA) may be less
adipogenic and may inhibit adipose tissue development by
attenuating the production of eicosanoids [2,3]. Moreover, n-3
LC-PUFA may have a regulatory effect on adiponectin [4]. Adipo-
nectin is an anti-inﬂammatory hormone secreted by adipose tissue
[4]. Decreased adiponectin concentrations are associated with
obesity and insulin resistance [4,5]. Several studies have shown a
positive association between n-3 LC-PUFA and adiponectin con-
centrations [4,6].
Adipocyte development increases exponentially with gesta-
tional age [7]. The highest increase in number and size of
adipocytes occurs during the ﬁrst year of life. Following this, the
differentiation of precursor cells into adipocytes continues later in
life [2,8]. Thus, pre- and early postnatal life are critical periods for
adipose tissue development.
However, it is not clear whether there is a long lasting priming
effect of n-3 LC-PUFA concentrations in cord blood on adiponectin
concentrations later in life [7].
In a previous analysis based on the same study population, we
reported a time-varying association between the n-6/n-3 ratio in
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cord blood and BMI (body mass index) up to the age of 10 years
[9]. Based on these ﬁndings, we investigated the association bet-
ween the n-3 LC-PUFA concentrations, the n-6 LC-PUFA concen-
trations and the n-6/n-3 ratio in cord blood with adiponectin
concentrations at the age of 10 years. The n-3 LC-PUFA concentra-
tions, the n-6 LC-PUFA concentrations and the n-6/n-3 ratio,
measured at the 10-year follow-up examination, were included
in the analysis in order to rule out confounding by life-style or
dietary factors, which may be reﬂected in the fatty acid composi-
tion in blood. We hypothesize that higher n-3 LC-PUFA concentra-
tions, lower n-6 LC-PUFA concentrations and a lower n-6/n-3 ratio
in cord blood are associated with higher adiponectin concentra-
tions at 10 years of age, even after accounting for later LC-PUFA
concentrations in blood.
2. Materials and methods
2.1. Study population
LISAplus (Life-style Related Factors on the Immune System and the
Development of Allergies in Childhood PLUS the inﬂuence of trafﬁc
emissions and genetics) is a German population based birth cohort
study in which a total of 3097 neonates were recruited between 1997
and 1999 from the cities of Munich, Leipzig, Wesel and Bad Honnef.
Details of the study design have been described elsewhere [10].
During the recruitment in maternity wards, cord blood samples were
collected and deep frozen until the time of measurement. Question-
naires were completed by the parents at birth, 0.5, 1, 1.5, 2, 4, 6 and 10
years of age, and physical examinations took place at 2, 6 and 10 years.
This sub-study is restricted to children from the Munich study
center. Of the 1467 successfully recruited children, 814 cord blood
samples could be collected. Total immunoglobulin E concentrations
were measured in these 814 cord blood samples [10]. Sufﬁcient serum
remained in 681 samples for further measurements of fatty acids. Of
the 1467 children recruited at birth, 953 (65%) were followed-up until
the age of 10 years. Of these 953 children, 581 children participated in
the clinical examination of which 540 provided blood samples.
Adiponectin concentrations and the fatty acid composition at age 10
years were measured successfully in 527 samples. Complete informa-
tion on the fatty acid composition in cord blood as well as adiponectin
concentrations and fatty acid composition at age 10 years was
available for 249 children. After excluding 12 children with missing
covariable information, 237 children were included in this analysis.
Approval by the local Ethics Committees (Bavarian Board of
Physicians, University of Leipzig, Board of Physicians of North-
Rhine-Westphalia) and written consent from each participant's
family were obtained.
2.2. Physical examination and blood tests
Blood samples were collected during the physical examination at
10 years of age. The analysis of adiponectin, estradiol and testosterone
has been previously described [11]. Blood samples were centrifuged
after collection and stored frozen at 80 1C until assayed for adip-
onectin, estradiol (females) and testosterone (males). Adiponectin
concentrations in serum were measured using a commercially avail-
able radioimmunoassay (Mediagnost, Reutlingen). The samples were
diluted by a factor of 1:300. The sensitivity of the test was 0.6 μg/L.
The intra- and interassay coefﬁcients of variation were between 2.35%
and 8.59% for adiponectin samples ranging from 3.36 mg/L to
15.19 mg/L. Testosterone and estradiol concentrations were measured
in the serum samples by the fully mechanized immunoassay system
Modular (Roche, Mannheim, Germany). The analytical sensitivity was
0.087 nmol/L for testosterone and 18.4 pmol/L for estradiol. Intra- and
interassay coefﬁcients of variation were below 4.06% and 2.83% for
6.2 nmol/L and 20.2 nmol/L testosterone, respectively. For estradiol,
intra- and interassay coefﬁcients of variation were below 5.29% and
3.56% for 378 pmol/L and 1941 pmol/L, respectively.
The measurement of fatty acids has been previously described in
detail for the serum from cord blood and from blood samples coll-
ected at 2, 6 and 10 years of age [9,12,13].
The analysis was performed by selective transfer of glyceropho-
spholipid fatty acids from 100 μl serum into their methyl esters and
their gas chromatographic separation and quantiﬁcation [14].
The total n-6 LC-PUFA concentration was calculated by sum-
ming the concentrations of eicosadienoic acid (C20:2n-6), dihomo-
gamma-linolenic acid (C20:3n-6), AA (C20:4n-6), adrenic acid
(C22:4n-6) and docosapentaenoic acid (C22:5n-6). Similarly, the
total n-3 LC-PUFA concentration was calculated by summing the
concentrations of eicosatrienoic acid (C20:3n-3), EPA (C20:5n-3),
docosapentaenoic acid (DPA, C22:5n-3) and DHA (C22:6n-3). Total
n-6 LC-PUFA and total n-3 LC-PUFA concentrations are presented
as a percentage of the concentrations of all the measured fatty
acids with 14–24 carbon atoms. The n-6/n-3 ratio was calculated
by dividing the total n-6 LC-PUFA concentration by the total n-3
LC-PUFA concentration.
2.3. Statistical analysis
The percentages of n-3 and n-6 LC-PUFA as well as the n-6/n-3
ratio were categorized into sex-speciﬁc tertiles because of their
apparent non-linear relationship with adiponectin concentrations.
The cut-off values used for the construction of tertile groups are
presented in Table S1 (Supplementary data). Adiponectin concen-
trations are presented using their mean and standard deviation
(SD) and differences in adiponectin concentrations between tertile
groups were tested using ANOVA (analysis of variance).
Linear regression models were applied to model the association
between adiponectin concentrations with n-6 and n-3 LC-PUFA and
the n-6/n-3 ratio tertiles. The ﬁrst tertile was used as the reference
category. Results are presented as linear regression coefﬁcient betas
with corresponding standard errors (SE). p-values were derived from
ANOVA. The linear regression models were adjusted for sex, total
serum glycerophosopholipid fatty acids in cord blood and at 10 years,
fasting status and exact age at the 10-year examination, BMI at 10
years, maternal age at birth, maternal pre-pregnancy BMI, maternal
education level (low/medium vs. high), birth weight (o3455 g vs.
Z3455 g), gestational age, breastfeeding (exclusive breastfeeding 44
months vs. no exclusive breastfeeding or exclusive breastfeeding r4
months), onset of puberty (females: estradiol 418.4 vs. r18.4;
males: testosterone 40.09 vs. r0.09). Furthermore, models were
adjusted for n-6 LC-PUFA, n-3 LC-PUFA and the n-6/n-3 ratio tertiles,
respectively, at age 10 years. To investigate if a speciﬁc LC-PUFA might
be causing the effect, all LC-PUFA previously combined into either n-3
or n-6 LC-PUFA, were analyzed separately. Additionally, a sensitivity
analysis stratiﬁed by sex was conducted. Statistical signiﬁcance was
deﬁned by a two-sided alpha level of 5%.
Statistical analyses were performed using R, version 2.15.2
(http://www.R-project.org/) [15]. The “effects” package was used
for plotting [16].
3. Results
This analysis is based on 237 children (110 girls and 127 boys) with
available information on cord blood fatty acid composition, fatty acid
composition and adiponectin measurements at age 10 years.
Details of the study population are presented in Table 1. The
mean adiponectin concentration was 9.5 ng/mL (SD¼4.2 ng/mL).
The characteristics of the study population per n-6 and n-3
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LC-PUFA and the n-6/n-3 ratio tertiles are presented in Table S2
(Supplementary data).
To investigate the effect of selective drop out, all variables were
tested for differences between participants and non-participants
(Supplementary data, Table S3). Non-participants were deﬁned as
children with available fatty acid measurements in cord blood but not
at 10 years of age. Children included in this study had higher adi-
ponectin concentrations at 10 years of age (p¼0.01) and were more
likely to be from older mothers (p¼0.03).
There was no signiﬁcant association between n-3 LC-PUFA, n-6
LC-PUFA or the n-6/n-3 ratio from cord blood and at age 10 years
(data not shown).
Table 2 presents mean adiponectin concentrations per n-6 and n-3
LC-PUFA and the n-6/n-3 ratio tertiles, in cord blood and at 10 years of
age. Mean adiponectin concentrations differed signiﬁcantly across the
tertiles of n-3 LC-PUFA in cord blood (T1: mean (SD)¼8.3 (3.7), T2:
11.0 (5.0), T3: 9.4 (4.0), po0.01) and the n-6/n-3 ratio in cord blood
(T1: 9.7 (4.3), T2: 10.0 (4.0), T3: 8.5 (3.8), p¼0.03). There were no
signiﬁcant differences in mean adiponectin concentrations across n-6
LC-PUFA tertiles in cord blood or n-6 LC-PUFA, n-3 LC-PUFA and the n-
6/n-3 ratio tertiles in blood measured at age 10 years.
Results of the linear regression models are presented in Table 3.
Adiponectin concentrations were associated with cord blood n-3 LC-
PUFA tertiles (T2 vs. T1: Beta (SE)¼1.84 (0.65); T3 vs. T1: 1.02 (0.68),
po0.01) and the cord blood n-6/n-3 ratio tertiles (T2 vs. T1: 0.14
(0.67), T3 vs. T1: 1.37 (0.68), p¼0.03). The cord blood n-6 LC-PUFA
tertiles were not associated with adiponectin concentrations.
Fig. 1 illustrates the associations between cord blood n-3 LC-
PUFA tertiles and the n-6/n-3 ratio with adiponectin concentra-
tions. The adjusted means of adiponectin concentrations per cord
blood n-3 LC-PUFA tertile are presented in Fig. 1a. The adjusted
mean of adiponectin concentrations was lowest in the ﬁrst tertile
and highest in the second tertile. Fig. 1b illustrates the association
between the n-6/n-3 ratio in cord blood and adiponectin concen-
trations. The adjusted means of adiponectin concentrations are
similar in the ﬁrst and second tertiles, and lower in the third.
To investigate if a speciﬁc LC-PUFA might be causing the effect, all
LC-PUFA previously combined into either n-3 or n-6 LC-PUFA, were
analyzed separately. The results are presented in Table S4 (Sup-
plementary data). Adiponectin concentrations were signiﬁcantly asso-
ciated with cord blood DPA (C22:5n-3) and DHA (C22:6n-3) tertiles,
but not with tertiles of eicosatrienoic acid (C20:3n-3), EPA (C20:5n-3)
or any of the n-6 LC-PUFA. There were no signiﬁcant associations of
adiponectin concentrations with any of the tertiles of n-6 LC-PUFA or
n-3 LC-PUFA in blood measured at age 10 years.
In an additional sensitivity analysis, linear regression models stra-
tiﬁed by sex were conducted (Supplementary data, Table S5). Gen-
erally, the magnitude of the effect estimates was stronger in females
(Table S5a) than in males (Table S5b). The association between cord
blood n-3 LC-PUFA tertiles and adiponectin concentrations reached
signiﬁcance only in females (T2 vs. T1: 2.23 (1.05), T3 vs. T1: 1.64
(1.11), p¼0.04). At 10 years of age, a higher n-6/n-3 ratio was
associated with higher adiponectin concentrations in females only
(T2 vs. T1: 1.60 (1.03), T3 vs. T1: 3.04 (1.05), p¼0.02), whereas there
was no association in males.
4. Discussion
Using longitudinal data from the Munich LISAplus birth cohort,
this study investigated the association between cord blood n-3 and
n-6 LC-PUFA concentrations as well as the n-6/n-3 ratio in cord
blood with adiponectin concentrations at 10 years of age, after
accounting for LC-PUFA concentrations in blood at 10 years of age.
Our results suggest the existence of a positive association between
cord blood n-3 LC-PUFA and adiponectin concentrations at 10 years of
age, whereas this association seems to be mainly caused by DPA and
DHA. Concentrations of LC-PUFA were grouped into tertiles because of
their apparent non-linear relationship with adiponectin concentra-
tions in our data, as observed in preliminary analyses. The risk
estimate for the second tertile was greater than that for the third
tertile (compared to the ﬁrst tertile). As the range of cord blood n-3
LC-PUFA concentrations was much greater in the third tertile (despite
the fact that the same number of observations are included in this
category as in the second and ﬁrst tertiles), our risk estimate for this
group is likely less accurate. Thus, we are unable to comment as to
whether our results indicate the existence of a non-linear association
between cord blood n-3 LC-PUFA percentages and adiponectin con-
centrations. The association between the n-6/n-3 ratio in cord blood
and adiponectin concentrations might be due to the fact that the third
tertile is mainly comprised of children with low cord blood n-3 LC-
PUFA concentrations. Thus, the effect estimate for the n-6/n-3 ratio in
this tertile is likely primarily driven by cord blood n-3 LC-PUFA conc-
entrations.
To our knowledge, this is the ﬁrst study that investigates the
association between cord blood n-3 and n-6 LC-PUFA concentrations
as well as the n-6/n-3 ratio with adiponectin concentrations at 10
years, after accounting for LC-PUFA composition at 10 years. A rand-
omized controlled trial comprising 533 women conducted by Rytter
et al. [17] investigated the effect of maternal ﬁsh oil intake during
pregnancy, as an indicator for n-3 LC-PUFA, on adiposity and related
outcomes in 19-year old offsprings. Adiponectin concentrations mea-
sured when the 243 offspring were 19 years of age did not differ
between the groups. The 19-year follow-up of this previous study is
longer than the current study's 10-year follow-up. It might thus be
possible that the associations we observed at 10 years are no longer
apparent during early adult life. Moreover, our study is an
Table 1
Characteristics of study population.
% or mean (SD)
Baseline (birth)
Sex [% females] 46%
Total fatty acidsa 647.3 (104.9)
Maternal age at birth [years] 33 (3.9)
Maternal BMI before pregnancy 22.1 (3.4)
Maternal education level [% high] 65%
Birth weight¼3455 g 50%
Gestational age [weeks] 40 (1.2)
Exclusive breastfeeding 44 months 51%
Follow-up (10 years)
Adiponectin [ng/mL] 9.5 (4.2)
Age in years 10.2 (0.2)
Total fatty acidsa 1256.3 (203.8)
Fasting [% yes] 22%
BMI 16.8 (2.4)
Onset of puberty [% yes] 45%
a Fatty acids were measured in serum glycerophosopholipids.
Table 2
Mean (SD) adiponectin concentrations per tertile of n-6 and n-3 LC-PUFA concen-
trations and the n-6/n-3 ratio.
T1 T2 T3 p-valueb
Cord blood n-6 LC-PUFAa 9.2 (3.9) 9.5 (4.5) 9.7 (4.0) 0.73
n-3 LC-PUFAa 8.3 (3.7) 11.0 (5.0) 9.4 (4.0) o0.01
n-6/n-3 ratioa 9.7 (4.3) 10.0 (4.0) 8.5 (3.8) 0.03
10 years n-6 LC-PUFAa 8.8 (3.6) 9.8 (4.3) 9.7 (4.6) 0.26
n-3 LC-PUFAa 9.5 (4.0) 10.0 (4.6) 8.8 (3.6) 0.18
n-6/n-3 ratioa 8.6 (3.6) 9.7 (4.3) 10.0 (4.0) 0.06
a Fatty acids were measured in serum glycerophosopholipids and the percen-
tages of n-6 and n-3 LC-PUFAs and the n-6/n-3 ratio are categorized into tertiles.
b p-value derived from ANOVA.
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observational study in a low ﬁsh intake population [18]. Thus, we are
unable to determine whether the observed beneﬁcial effect of cord
blood n-3 LC-PUFA on adiponectin concentrations at age 10 years is
caused by residual confounding.
Our results showed a positive signiﬁcant association between adip-
onectin concentrations and the tertiles of the n-6/n-3 ratio at 10 years
of age in females (Supplementary data, Table S5a). These ﬁndings are
not well understood so far and the results in adults are conﬂicting
[19–22]. Adiponectin concentrations in life course are complex and
change over time in females [23]. Between the age of 5 and 8 years,
adiponectin concentrations decrease independent of BMI. However,
beyond this age, adiponectin concentrations show a negative associa-
tion with percentage of body fat.
The biological mechanisms through which n-3 LC-PUFA may
increase adiponectin concentrations are not entirely clear. The n-3
LC-PUFA EPA and DHA appear to activate the peroxisomal prolifera-
tor-activated receptor γ (PPARγ), which can stimulate adiponectin
synthesis [24,25]. Furthermore, n-3 LC-PUFA may promote the synth-
esis of anti-inﬂammatory resolvins and protectins, which also enhance
adiponectin production [26,27].
The major strength of this study is its prospective, longitudinal
birth cohort study design, which includes a long follow-up period of
up to 10 years of age and repeated fatty acid measurements. This
study is a sub-study of the LISAplus birth cohort and not all blood
measurements were available for all participants. Therefore, the
sample size used for analysis is considerably smaller than the original
cohort size. Another limitation of this study is the potential bias
associated with non-random loss to follow-up (Supplementary data,
Table S3). The fact that all fatty acid measurements were conducted at
the same time (after the 10-year follow-up) with identical lab
methods is on one hand a strength, but may also be a limitation as
the storage time was substantially longer for cord blood samples than
blood samples collected at the 10-year follow-up. Longer storage, even
at 80 1C, might induce losses due to peroxidation, particularly of
polyunsaturated fatty acids. This may potentially reduce the correla-
tion between cord blood fatty acids and fatty acids at 10 years of age,
and to adiponectin, thus underestimating the association between
cord blood fatty acids and later-life adiponectin concentrations. In our
study, glycerophopholipid bound fatty acids were measured. As
expected, the mean percentages of DHA and AA are higher when
measured in glycerophospholipids compared to total lipids [28–30].
Further, the mean percentages of glycerophopholipid DHA and AA are
slightly higher compared to those measured in phospholipids [31,32].
Phospholipids combine glycerophopholipids and sphingomyelins,
which are relatively low in polyunsaturated fatty acids.
Our results need to be conﬁrmed in further studies with adequate
sample size, long-term follow-up and repeated measurements to
assess the persistence and possible beneﬁcial health consequences.
In summary, cord blood n-3 LC-PUFA concentrations and the n-6/n-3
ratio in cord blood appear to be associated with adiponectin concen-
trations at 10 years of age.
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